University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
NCT Number: NCT03056820
The purpose of this study is to compare the effect of the 25° head-up position versus the 55° head-up position on tolerable apnea time (TAT) after induction of general anesthesia in patients with a body mass index (BMI) of 30-40.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kansas City, Kansas, 66160, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant will be positioned at 25° angle for procedure.
Participant will be positioned at 55° angle for procedure.
Time frame: Time between start of induction of general anesthesia (SpO2 100%) to decline of SpO2 94%, up to eight minutes
Measure of the TAT between groups to determine if the TAT is a function of the participant's position.
Time frame: Time between start of the tracheal intubation procedure to completion of tracheal intubation, up to 2 minutes
Time frame: Time until SpO2 decreased to 92%, up to 8 minutes
Measure of the rebound SpO2. It is the lowest SpO2 reading reached subsequent to start of mechanical ventilation at the SpO2 value of 94% and it represents final completion of SpO2 decline.
University of Kansas Medical Center
Other
Comparison of Apnea Tolerance in Two Positions of Patients With Body Mass Index (BMI) 30-40
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03115931
Clinical Outcomes, General Surgery
Nanjing, Jiangsu, China
View Trial DetailsNCT05253339
Anti-bacterial Agents, General Surgery
Seoul, Songpa-Gu,, South Korea
View Trial DetailsNCT04660721
Cardiovascular Diseases, Embolism and Thrombosis
St Louis, Missouri, United States
View Trial DetailsNCT06333639
General Surgery, Orthopedic Procedures
Nice, Alpes Maritimes, France
View Trial Details